Literature DB >> 26314230

First report of equine Pegivirus in South America, Brazil.

Alex Junior Souza de Souza1, Andreza Pinheiro Malheiros2, Erika Rocha Paraense de Sousa3, Alba Cristina Negrão Moreira3, Andrea Lima Silva2, André Antônio Corrêa das Chagas2, Pedro Eduardo Bonfim Freitas2, Bernard Salame Gemaque2, Heriberto Ferreira de Figueiredo4, Lilian Rose Marques de Sá5, Paloma Daguer Ewerton Dos Santos6, Manoel do Carmo Pereira Soares2.   

Abstract

The human Pegivirus (HPgV, also known as GBV-C virus or hepatitis G virus) is a lymphotropic RNA-virus phylogenetically related to the Hepatitis C virus, which infects approximately 5% of the world's human population. Recently, two novel, presumably hepatotropic, pegiviruses, designated as equine Pegivirus (EPgV) and Theiler's Disease Associated Virus (TDAV), were discovered in horses with clinical and laboratory evidence of hepatic disease. To verify the occurrence of pegiviruses infection in horses from Pará State, northern Brazil, serum samples from 114 horses located in four cities (Acará, Belém, Dom Eliseu and Ananindeua) were submitted for the molecular analysis of EPgV by nested RT-PCR. The results of nucleotide sequencing and phylogenetic analysis of EPgV NS3 and NS5B genomic regions confirmed one positive sample among 114 tested samples (1/114; 0.8%). No evidence of TDAV infection was found, but despite the low prevalence and unknown clinical significance among the studied population, these results represent the first molecular detection of EPgV in horses in South America.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  GBV; Horses; Pegivirus

Mesh:

Year:  2015        PMID: 26314230     DOI: 10.1016/j.actatropica.2015.08.014

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  6 in total

Review 1.  Human Pegivirus Type 1: A Common Human Virus That Is Beneficial in Immune-Mediated Disease?

Authors:  Jack T Stapleton
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

2.  Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis.

Authors:  Joy E Tomlinson; Raphael Wolfisberg; Ulrik Fahnøe; Himanshu Sharma; Randall W Renshaw; Louise Nielsen; Eiko Nishiuchi; Christina Holm; Edward Dubovi; Brad R Rosenberg; Bud C Tennant; Jens Bukh; Amit Kapoor; Thomas J Divers; Charles M Rice; Gerlinde R Van de Walle; Troels K H Scheel
Journal:  PLoS Pathog       Date:  2020-07-10       Impact factor: 6.823

3.  Semi-quantitative duplex RT-PCR reveals the low occurrence of Porcine Pegivirus and Atypical Porcine Pestivirus in diagnostic samples from the United States.

Authors:  Fangzhou Chen; Todd P Knutson; Eli Braun; Yin Jiang; Stephanie Rossow; Douglas G Marthaler
Journal:  Transbound Emerg Dis       Date:  2019-03-21       Impact factor: 5.005

Review 4.  Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication.

Authors:  Yaqi Yu; Zhenzhou Wan; Jian-Hua Wang; Xianguang Yang; Chiyu Zhang
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

5.  First Description of Hepacivirus and Pegivirus Infection in Domestic Horses in China: A Study in Guangdong Province, Heilongjiang Province and Hong Kong District.

Authors:  Gang Lu; Lingshuang Sun; Tao Xu; Dong He; Zengchao Wang; Shudan Ou; Kun Jia; Liguo Yuan; Shoujun Li
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

6.  Identification and genetic characterization of hepacivirus and pegivirus in commercial equine serum products in China.

Authors:  Gang Lu; Ji Huang; Qiliang Yang; Haibin Xu; Peixin Wu; Cheng Fu; Shoujun Li
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.